Follow WOWNEWS 24x7 on:
Cipla Ltd launched YurPeak in India after DCGI approval, targeting obesity and type 2 diabetes. The therapy strengthens Cipla’s chronic care portfolio and addresses rising lifestyle-related health challenges. Analysts see the move as strategically significant, enhancing patient outcomes and boosting investor confidence in Cipla’s innovation-led growth strategy.
Show moreStay Ahead – Explore Now! Garmin Soars: 2025 Forecast Beats Expectations on Booming Wearables Demand
Follow WOWNEWS 24x7 on:
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
